NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/27/2024
Back to search
Official data from USPTO
CAMBER PHARMACEUTICALS, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
01/27/2024
Trademark type
Combined
Nice classes
5
Filing date
12/13/2011
Registration date
08/20/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/27/2024
Last transaction
01/27/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2007-10-00
First use in commerce
2007-10-00
Drawing code
3
Owner type
03
Owner location
Piscataway, NJ, US
Examiner
HETZEL, DANNEAN
Law office
L60
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the words "CAMBER PHARMACEUTICALS, INC." and a design element.
Holders and representatives
Holders
Camber Pharmaceuticals, Inc.
Representatives
John Thallemer Hetero USA, Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
A full line of pharmaceutical preparationsboth prescription and over-the-counterfor human use
Publications
History of USPTO decisions and trademark events.
34 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/27/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/27/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/27/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
08/01/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/20/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/19/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/19/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/19/2019
E815
TEAS SECTION 8 & 15 RECEIVED
08/13/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/20/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/25/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
08/20/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2013
PUBO
PUBLISHED FOR OPPOSITION
06/04/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/15/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/27/2013
ALIE
ASSIGNED TO LIE
04/27/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/17/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/16/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/15/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/15/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/16/2012
GNRT
NON-FINAL ACTION E-MAILED
10/16/2012
CNRT
NON-FINAL ACTION WRITTEN
10/16/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/27/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/26/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/26/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/26/2012
GNRT
NON-FINAL ACTION E-MAILED
03/26/2012
CNRT
NON-FINAL ACTION WRITTEN
03/26/2012
DOCK
ASSIGNED TO EXAMINER
03/22/2012
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
12/21/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/20/2011
Continuous trademark protection
Get notified about every new filing that threatens CAMBER PHARMACEUTICALS, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.